
Global clinical trials examining the potential of blood thinners to treat moderately ill COVID-19 patients have proven so successful that physicians should immediately start using them in standard care, some Canadian doctors say.
from CBC | Health News https://ift.tt/39YtBUn
Aucun commentaire:
Enregistrer un commentaire